Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases. Its technology targets the vascular-rich upper nasal cavity and provides rapid absorption, consistent drug biodistribution. The company specializes in the treatment of such diseases as migraine, autism spectrum disorder, and Parkinson's disease.